Literature DB >> 16225032

Milk thistle.

Francine Rainone1.   

Abstract

Milk thistle has been used as a cytoprotectant for the treatment of liver disease, for the treatment and prevention of cancer, and as a supportive treatment of Amanita phalloides poisoning. Clinical studies are largely heterogeneous and contradictory. Aside from mild gastrointestinal distress and allergic reactions, side effects are rare, and serious toxicity rarely has been reported. In an oral form standardized to contain 70 to 80 percent silymarin, milk thistle appears to be safe for up to 41 months of use. Significant drug reactions have not been reported. Clinical studies in oncology and infectious disease that are under way will help determine the efficacy and effectiveness of milk thistle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225032

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  18 in total

1.  Silymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis.

Authors:  Hílton Antônio Mata-Santos; Fabianno Ferreira Dutra; Carolina Carneiro Rocha; Fabiana Gonçalves Lino; Fabiola Ramos Xavier; Leandro Andrade Chinalia; Bryan Hudson Hossy; Morgana Teixeira Lima Castelo-Branco; Anderson Junger Teodoro; Claudia N Paiva; Alexandre dos Santos Pyrrho
Journal:  Antimicrob Agents Chemother       Date:  2014-01-21       Impact factor: 5.191

2.  Identification of hepatoprotective flavonolignans from silymarin.

Authors:  Stephen J Polyak; Chihiro Morishima; Volker Lohmann; Sampa Pal; David Y W Lee; Yanze Liu; Tyler N Graf; Nicholas H Oberlies
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

Review 3.  Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

Review 4.  Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.

Authors:  Tomas Koltai; Larry Fliegel
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

5.  Effect of herbal cream containing Fumaria officinalis and silymarin for treatment of eczema: A randomized double-blind controlled clinical trial.

Authors:  Fariba Iraji; Behzad Sharif Makhmalzadeh; Mahya Abedini; Ali Aghaei; Amir Siahpoush
Journal:  Avicenna J Phytomed       Date:  2022 Mar-Apr

Review 6.  Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer.

Authors:  Samiha Mateen; Komal Raina; Rajesh Agarwal
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

7.  Multiple effects of silymarin on the hepatitis C virus lifecycle.

Authors:  Jessica Wagoner; Amina Negash; Olivia J Kane; Laura E Martinez; Yaakov Nahmias; Nigel Bourne; David M Owen; Joe Grove; Claire Brimacombe; Jane A McKeating; Eve-Isabelle Pécheur; Tyler N Graf; Nicholas H Oberlies; Volker Lohmann; Feng Cao; John E Tavis; Stephen J Polyak
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

8.  Silibinin down-regulates FAT10 and modulate TNF-α/IFN-γ-induced chromosomal instability and apoptosis sensitivity.

Authors:  Yun Gao; Steven Setiawan Theng; Way-Champ Mah; Caroline G L Lee
Journal:  Biol Open       Date:  2015-07-03       Impact factor: 2.422

9.  Protective effect of silymarin on noise-induced hearing loss in Guinea pigs.

Authors:  Ghassem Mohammadkhani; Akram Pourbakht; Mahnaz Khanavi; Soghrat Faghihzadeh
Journal:  Iran Red Crescent Med J       Date:  2013-11-05       Impact factor: 0.611

10.  Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship.

Authors:  Chapla Agarwal; Ritambhara Wadhwa; Gagan Deep; David Biedermann; Radek Gažák; Vladimír Křen; Rajesh Agarwal
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.